Pfizer Postpones FDA Request For COVID Vaccine For Children Under 5

On Friday, Pfizer and BioNTech announced that they are postponing their application to the FDA for their COVID-19 vaccine to be approved for children ages six months to four years old. According to Axios, the companies said they “will wait for the three-dose data” because they “believe it may provide a higher level of protection in this age group.” “The trial in children 6 months through 4 years of age is ongoing and data on the first two … doses in this age group are being shared with the FDA on an ongoing basis,” Pfizer said in a statement. “Cases continue to


